Role of FXR and TGR5 in Age Related Renal Diseases
FXR 和 TGR5 在年龄相关性肾脏疾病中的作用
基本信息
- 批准号:9346676
- 负责人:
- 金额:$ 7.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2017-10-01
- 项目状态:已结题
- 来源:
- 关键词:Acute Renal Failure with Renal Papillary NecrosisAdultAffectAgeAgingAgonistAlbuminsAlbuminuriaAntioxidantsAttenuatedBaltimoreBile AcidsBiogenesisBlood VesselsCaloric RestrictionChronic Kidney FailureCicatrixCoupledDevelopmentDiseaseEarly InterventionElderlyEnd stage renal failureExcretory functionExtracellular MatrixExtracellular Matrix ProteinsFatty AcidsFibrosisG-Protein-Coupled ReceptorsG-substrateGPBAR1 geneGTP-Binding ProteinsGenderGenerationsGlomerular Filtration RateImpairmentIndividualInflammationInjuryInterventionKidneyKidney DiseasesKnock-outKnockout MiceLipidsLongitudinal StudiesMembraneMitochondriaMolecularMusNuclear Hormone ReceptorsNuclear ReceptorsOlder PopulationOxidative StressPlayProcessRaceReactive Oxygen SpeciesRegulationRenal TissueRenal functionRoleSIRT1 geneSclerosisSignal TransductionSirtuinsTestingTherapeutic AgentsTimeTransgenic MiceUnited StatesVariantage relatedagedfarnesoid X-activated receptorglomerulosclerosishealthy agingimprovedinnovationinterstitiallipid metabolismnoveloverexpressionoxidationpodocytepreventpublic health relevancereceptorurinary
项目摘要
DESCRIPTION (provided by applicant): A gradual decline in renal function occurs in healthy aging individuals. Aging may exacerbate Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD). About more than half of the CKD cases and majority of the end stage renal disease (ESRD) occur in the older population. These findings highlight the importance of kidney aging and its potential contribution to AKI, CKD and ESRD in the elderly. Since the population older than 65 years in the United States is expected to double during the next 20 years, focus on potential early intervention strategies for age-associated renal injury and disease becomes critical. We will test the hypothesis that the age-related decreases in nuclear hormone receptor FXR and G protein coupled membrane receptor TGR5 expression play an important role in age-related kidney disease by impairing mitochondrial function, which results in a) increased generation of mitochondrial reactive oxygen species (ROS) and decreased generation of mitochondrial antioxidants, causing increased oxidative stress and inflammation, and b) decreased mitochondrial fatty acid ß-oxidation, causing increased renal lipid accumulation. We propose that FXR and/or TGR5 agonists or overexpression will prevent or markedly reduce age-related decline in glomerular filtration rate (GFR), increase in albuminuria, podocyte loss, and accumulation of extracellular matrix proteins (fibrosis) by improving mitochondrial function, which results in a) decreased generation of mitochondrial reactive oxygen species (ROS) and increased generation of mitochondrial antioxidants, causing decreased oxidative stress and inflammation, and b) increased mitochondrial fatty acid ß-oxidation, causing decreased renal lipid accumulation. In SPECIFIC AIM 1, we will determine the role of FXR and TGR5 in progression of age-related renal disease. We will also perform mechanistic studies to determine how alterations in kidney bile acid composition regulate podocyte function. In SPECIFIC AIM 2, we will perform mechanistic studies to determine if FXR and TGR5 protect against age-related renal disease by Sirtuin 3 dependent mechanisms. Impact and Innovation: 1) The hitherto unrecognized roles of: i) nuclear receptor FXR, ii) G protein coupled receptor TGR5 and iii) the potential of dual FXR/TGR5 agonists as therapeutic agents for treating age- associated renal disease and complications. 2) The novel and distinct role of FXR and TGR5 agonists in regulation of mitochondrial function, oxidative stress, inflammation, and lipid metabolism, as they relate to age- associated renal conditions. 3) TGR5/FXR signaling mimics that of caloric restriction (CR), potentially leading to new intervention strategies for age-related kidney injury and complications. 4) Mechanistic studies to determine the roles of the bile acids and mitochondrial Sirtuin 3 in modulation of age-related renal disease.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MOSHE LEVI其他文献
MOSHE LEVI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MOSHE LEVI', 18)}}的其他基金
Role of Estrogen Related Receptors in Age Related Kidney Disease
雌激素相关受体在年龄相关性肾脏疾病中的作用
- 批准号:
10320972 - 财政年份:2020
- 资助金额:
$ 7.28万 - 项目类别:
Role of Estrogen Related Receptors in Age Related Kidney Disease
雌激素相关受体在年龄相关性肾脏疾病中的作用
- 批准号:
10154246 - 财政年份:2020
- 资助金额:
$ 7.28万 - 项目类别:
Role of Estrogen Related Receptors in Age Related Kidney Disease
雌激素相关受体在年龄相关性肾脏疾病中的作用
- 批准号:
10535466 - 财政年份:2020
- 资助金额:
$ 7.28万 - 项目类别:
Role of FXR and TGR5 in Age Related Renal Diseases
FXR 和 TGR5 在年龄相关性肾脏疾病中的作用
- 批准号:
8984793 - 财政年份:2016
- 资助金额:
$ 7.28万 - 项目类别:
Non-Invasive Evaluation of Transplant Kidney using OCT
使用 OCT 对移植肾进行无创评估
- 批准号:
9259961 - 财政年份:2014
- 资助金额:
$ 7.28万 - 项目类别:
Treatment of Kidney Disease in Diabetes and Obesity
糖尿病和肥胖症肾病的治疗
- 批准号:
8743204 - 财政年份:2013
- 资助金额:
$ 7.28万 - 项目类别:
Treatment of Kidney Disease in Diabetes and Obesity
糖尿病和肥胖症肾病的治疗
- 批准号:
9140010 - 财政年份:2013
- 资助金额:
$ 7.28万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 7.28万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 7.28万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 7.28万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 7.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 7.28万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 7.28万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 7.28万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 7.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 7.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 7.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




